Isocitrate dehydrogenase mutations are associated with altered IL-1β responses in acute myeloid leukemia

Area of Science:

• Cell Biology
• Immunology
• Cancer Biology

Background:

• Isocitrate dehydrogenase 2 (IDH2) mutations influence cellular differentiation and epigenetic modifications.
• The impact of IDH2 mutations on intracellular signaling pathways remains largely unexplored.

Purpose of the Study:

• To investigate the effects of IDH2 mutations on cellular differentiation and intracellular signaling.
• To determine the response of IDH2 mutant cells to inflammatory immune ligands, specifically IL-1β.

Main Methods:

• Utilized an isogenic cell line model to study IDH2 mutant cells.
• Employed phospho-specific flow cytometry and mass cytometry to analyze signaling responses.
• Conducted bulk and single-cell RNA sequencing to assess transcriptional changes.
• Investigated targeted inhibition of the IKK complex in primary leukemia samples.

Main Results:

• IDH2 mutant cells exhibited augmented responses to inflammatory immune ligands, particularly IL-1β.
• Demonstrated increased sensitivity of IDH2 mutant cells to IL-1β at multiple downstream signaling readouts.
• Confirmed elevated cytokine-related signaling pathways and NF-κB target gene expression via RNA sequencing.
• Observed altered IL-1β transcriptional responses in IDH2 mutant cells using single-cell RNA sequencing.

Conclusions:

• IDH2 mutations significantly alter intracellular signaling, leading to heightened sensitivity to IL-1β.
• The IL-1β signaling pathway represents a potential therapeutic target in IDH2-mutated cancers.
• Targeted inhibition of the IKK complex showed promise in reducing IL-1β responses and inducing cell death in primary IDH-mutated leukemia.